ADLYXIN

Found in: United States

Active ingredients

#
Active Ingredient
Description
1

Lixisenatide is a selective GLP-1 receptor agonist. The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells.

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 0024-5747